生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM). The rate of onset of inhibition by low concentrations of ifenprodil acting at NR1A/NR2B receptors was considerably slower than the onset of inhibition seen with high concentrations of ifenprodil acting at NR1A/NR2A receptors. The degree of inhibition seen with 100 microM ifenprodil at NR1A/NR2A receptors was not altered by changes in the concentration of extracellular glycine. However, the inhibitory effect of 1 microM ifenprodil at NR1A/NR2B receptors was reduced by increasing the concentration of glycine[3]. Moreover, ifenprodil decreased NMDA receptor equilibrium open probability by raising an energetic barrier to activation and also by biasing the receptor toward low open probability gating modes[4]. A single injection of ifenprodil (3 mg/kg, intraperitoneally (i.p.)) was sufficient to provoke rapid antidepressant-like effects in chronic unpredictable mild stress (CUMS) rats. Moreover, ifenprodil activated mTOR signaling and reversed the CUMS-induced elevation of interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the hippocampus after acute administration[5]. In the basolateral amygdala, ifenprodil dose dependently blocks excitatory transmission to principal neurons by a presynaptic mechanism. Ifenprodil reduces synaptic transmission in the basolateral amygdala by partially blocking P-type voltage-dependent calcium channels[6]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01896388 | Posttraumatic Stress Disorders | Phase 1 Phase 2 | Recruiting | - | Japan ... 展开 >> Department of Psychiatry, Chiba University School of Medicine Chiba, Chuo-ku, Japan 260-8670 Recruiting Chiba, Chuo-ku, Japan, 260-8670 Contact: Tsuyoshi Sasaki, MD +81-43-222-7171 sasaki@faculty.chiba-u.jp Contact: Kenji Hashimoto, PhD +81-43-222-7171 hashimoto@faculty.chiba-u.jp Principal Investigator: Masaomi Iyo, MD,PhD 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.25mL 0.25mL 0.12mL |
6.24mL 1.25mL 0.62mL |
12.48mL 2.50mL 1.25mL |
参考文献 |
---|